Role of Aldehyde Dehydrogenase in Cyclophosphamide-resistant L 1210 Leukemia

Cancer Research

Volumn 44, Issue 11, 1984, Pages 5156-5160

  Hilton, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CYCLOPHOSPHAMIDE; PHOSPHORAMIDE MUSTARD;

4 METHYLCYCLOPHOSPHAMIDE; ANIMAL EXPERIMENT; CANCER CHEMOTHERAPY; DRUG RESISTANCE; LEUKEMIA L 1210; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY;

ALDEHYDE DEHYDROGENASE; ANIMAL; CELL SURVIVAL; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DNA, NEOPLASM; DRUG RESISTANCE; LEUKEMIA L1210; MICE; MICE, INBRED STRAINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021722034     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aukerrnan. S. L., Brundrett, R. B., Hlilon, J., and Hartman, P. E. Effect of plasma and carboxylostorasQ on the stabflty, mutagenicity, and DMA croee-Hdng activity of some direct-acting Af-nitroeo compounds. Cancer Res., 43: 175–181, 1983.
2. Borch, R. F. T. and Getman, K. M. Base catalysedI hydrotyate of 4-hydroperoxy-cyctophoephamide: evidence for iminocyctophoephernide as an Intermediate. J. Med. Chem., 27:486–490, 1964.
3. Chu, M. Y., and Fischer, G. A. Incorporation of cytoeine[2H]-arabinooide and its effect on murine leukemia cess (L5178Y). Biochem. Pharmacol., 17:753–767.1938.
4. Colvin, M., Brundrett, R. B., Kan. M-N. N., Jardne. I., and Fenselau. C. Alkylating properties of phosphoramide mustard. Cancer Res., 36: 1121–1126, 1976.
5. Cox, P. J., Phillips, B. J., and Thomas, P. Studtas on the selective action of cyclophosphamide (NSC-26271): (motivation of the hydroxylated metabolte by tissue-soluble enzymes. Cancer Treat Rep., 60:321–326, 1976.
6. DeWys, W. D. A dose-response study of resistant of leukemia L1210 to cyclophosphamide. J. Natl. Cancer Inst, 50:783–789, 1973.
7. Domeyer, B. E., and Stadek, N. E. Metaboism of 44iydroxycyotophosphamide/ aktophosphamide In vitro. Biochem. Pharmacol., 29:2903–2912, 1980.
8. Domeyer, B. E., and Stadek, N. E. Inhibition by cyanamide of 4-hydroxycyclo-phosphamide/aldophosphamide oxidation to carboxyphosphamide. Biochem. Pharmacol., 30:2065–2073, 1981.
9. Friedman, O. M., and Boger, E. Cotorimetric estimation of nitrogen mustards in aqueous medta. Anal. Chem., 33: 906–910, 1961.
10. Friedman, O. M., Mytes, A., and Colvn, M. Cyclophosphamide and related phosphoramide mustard. In: A. Rosowsky (ed.), Advances in Cancer Chemotherapy, Vol. 1, pp. 143–204. New York: Marcel Dekker, Inc., 1979.
11. Hlton, J. DNA crosslnking by 4-hydroperoxycyok)ph08phamide in cycJophos-phamide-sensitive and resistant L1210 cells. Biochem. Pharmacol., in press, 1984.
12. Hfton, J., and Cohen, D. Role of aldehyde dehydrogenase in the response of L1210 cells to cyclophosphamide and 4-methyteydophosphamide. Proc Am. Assoc. Cancer Res., 23:169, 1982.
13. Npkens, J. H., Struck, R.F., and Qurtoo.H.L. Role of aldehyo* dehydrogenase in the metalxrtsm-dependent biological activity of cyclophosphamide. Cancer Res. 41:3571–3583.1981.
14. Hohorst, H-J., Peter, G., and Struck, R. F. Synthesis of 4-hydroperoxy derivatives of ifoefamide and trofosfamide by oTrect ozonation and prelminary antitumor evaluation In vivo. Cancer Res., 36:2278–2281, 1976.
15. Kohn, K. W., Erickson, L. C., Ewig, R. A. Q., and Friedman, C. A. Fractionation of DNA from mammolan cats by akalne elution. Biochemistry, 75: 4629–4637, 1976.
16. Korblng, M., Hess, A. D., Tutschka, P. J., Katzer, H., Colvn, O. M., and Santos, Q. W. 4-Hydroperoxycydophospfiamide: a model for ellmlnating residual human tumour eels and T-rymphocytes from bone marrow graft Br. J. Haematol., 52:89–96, 1982.
17. Powers, J. F., and Stadek, N. E. Cytotoxic activity relative to 4-hydroxycyclo-phosphamide and phosphoramide mustard concentrations in the ptasma of cyctophosphamide-treated rats. Cancer Res., 43:1101–1106, 1983.
18. Redwood, W. R., Hlton, J., Corvin, M., and Owens, A. H., Jr. The celular uptake of 4-hydroperoxycydophosphamide. Proa Am. Assoc. Cancer Res., 23:169.1982.
19. Stadek, N. E. Bioassay and relative cytotoxic potency of cyclophosphamide metatbolles generated in vitro and in vivo. Cancer Res., 33:1150–1158, 1945.
20. Somogyi, M. Determination of blood sugar. J. Biol. Chem., 160:69–73, 1945.
21. Struck, R. P., Kirk. M. C. Wiu. M. H., and Laster. W. H., Jr. Isolation and mass spectral laentmcation or wood metaooites or cyqopnospnamioe and evidence for phosphoramide mustard as the biologloally active metabolte. Btomed. Mass Spectrom., 2:46–52.1975.
22. Takamizawa, A., Matsumoto, S., and fwata. T. 4-Hydroxycyctophoephamide anfiydro-olmer: revised structure of the Fenton oxidation product of cycto-phosphamide. Tetrahedron Lett. 6:517–520, 1974.